On June 17, Pledis Entertainment updated fans on the health status of Seventeen member Jeonghan, who recently underwent surgery for lateral epicondylitis and tendon damage in his right elbow. 

The agency stated,

"We would like to provide you with some information regarding SEVENTEEN member JEONGHAN’s elbow injury.

JEONGHAN has been receiving conservative treatment such as receiving injections for an infection and damage in his outer tendon on his right elbow. JEONGHAN recently visited the hospital due to increased pain in his elbow and received word from the medical staff that his lateral epicondylitis and tendon damage has worsened. It has been determined that surgery was needed which he received on Wednesday the 15th.

The operation was successful, and the artist hss been recuperating after being discharged as of Thursday the 16th. JEONGHAN will be wearing a cast for the time being, as well as a brace in order to protect the treated area, and to aid in a faster recovery.

The artist is highly determined to attend all of the group’s prearranged engagements; however, his participation will be adjusted depending on the circumstances, placing his recovery as the top most priority as per recommended by the medical staff.

As such, JEONGHAN will be participating in the group’s prearranged activities including the SEVENTEEN WORLD TOUR [BE THE SUN] in his cast and brace while continuously receiving medical consultations, so long as it does not put too much strain on his recovery. We ask our fans for your kind consideration.

We will do our best to aid in JEONGHAN’s treatment and recovery so that he can return in full health to his fans as quickly as possible.

Thank you."

Meanwhile, Seventeen will be kicking off their 2022 world tour 'Be The Sun' with their first stop in Seoul from June 25-26 at the Gocheok Sky Dome. The show on June 26 will also be streamed live online for global fans. 

The tour is slated to head to North America next beginning in August, stopping in a total of 12 cities across the the U.S. and Canada.